Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ... Jun 03
Until today, there were no approved medicines to treat patients with ATTR-CM in the EU... Feb 27
-Advertisements-